Invitation to Submit Proposal for Direct Adjustment for the Acquisition of A5356 - Fluocinolone Acetonide [190 µg; Intravitreal Implant; Applicator]

This tender invites proposals for the direct procurement of A5356, which is Fluocinolone Acetonide in a dosage of 190 µg intended for intravitreal implantation. The procurement is aimed at acquiring the necessary supplies to support medical treatments that require this specific medication. The tender outlines the need for a reliable supplier who can provide the product in compliance with regulatory standards and specifications. Key requirements may include the ability to deliver the product within a specified timeframe, adherence to quality control measures, and provision of necessary documentation to ensure the product's safety and efficacy. This procurement is crucial for healthcare providers who rely on such treatments for patients with specific ocular conditions. Interested parties are encouraged to submit their proposals, detailing their qualifications and capacity to meet the outlined requirements. The location of the procurement is not specified, but it is implied that it will serve healthcare facilities that require this medication. This tender represents an important opportunity for suppliers in the pharmaceutical sector to engage in public procurement processes and contribute to healthcare delivery.

This is a supplies contract in the health and medical services, information and communication technology and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 36,484.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.